Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552927 · ClinicalTrials.gov registry record · NA
Chest Shielding in Premature Infants During Phototherapy
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02552927 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 50 participants.
The verdict
NCT02552927, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a feasibility study where Infants will be randomized to either chest shielding with aluminum foil or chest shielding without aluminum foil while undergoing phototherapy for premature infants. The primary outcome is patent ductus arteriosus.
Interventions
- DEVICE SHIELD
- DEVICE Chest shield with aluminum foil (CALF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2019-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02552927
The ClinicalTrials.gov registry entry for NCT02552927 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SHIELD is the first listed.
NCT02552927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02552927 about?
NCT02552927 is a clinical study titled "Chest Shielding in Premature Infants During Phototherapy". This is a feasibility study where Infants will be randomized to either chest shielding with aluminum foil or chest shielding without aluminum foil while undergoing phototherapy for premature infants. The primary outcome is patent ductus arteriosus.
What is the current status of trial NCT02552927?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2015-08-01. Estimated completion is 2019-02-13.
What interventions are being tested in trial NCT02552927?
The interventions under investigation include: SHIELD (DEVICE), Chest shield with aluminum foil (CALF) (DEVICE).
Who is sponsoring clinical trial NCT02552927?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.